Does INTERFERON BETA-1A Cause Focal segmental glomerulosclerosis? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Focal segmental glomerulosclerosis have been filed in association with INTERFERON BETA-1A (Avonex). This represents 0.0% of all adverse event reports for INTERFERON BETA-1A.
8
Reports of Focal segmental glomerulosclerosis with INTERFERON BETA-1A
0.0%
of all INTERFERON BETA-1A reports
0
Deaths
3
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From INTERFERON BETA-1A?
Of the 8 reports, 3 (37.5%) required hospitalization.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INTERFERON BETA-1A. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does INTERFERON BETA-1A Cause?
Multiple sclerosis relapse (5,931)
Influenza like illness (4,475)
Memory impairment (3,468)
Multiple sclerosis (3,412)
Fatigue (3,164)
Fall (3,128)
Gait disturbance (3,031)
Death (2,766)
Pain (2,692)
Headache (2,533)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
Which INTERFERON BETA-1A Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
INTERFERON BETA-1A vs INTERFERON BETA-1B
INTERFERON BETA-1A vs INTERFERON GAMMA
INTERFERON BETA-1A vs INTERFERON GAMMA-1B
INTERFERON BETA-1A vs INVEGA
INTERFERON BETA-1A vs INVEGA SUSTENNA